Sorrento Therapeutics Inc. and SmartPharm Therapeutics Inc. recently announced a research and development collaboration in which they will work to develop a next-generation, gene-encoded antibody vaccine for COVID-19. Technology Networks spoke with SmartPharm's CEO Jose Trevejo to learn more about the collaboration and the next steps in the development of the vaccine.Read More
Vaccine development is a science over 200 years in the making, but creating a preventative that is effective and safe remains a complex and challenging task. Among the many companies working to create a vaccine for COVID-19 is Tonix Pharmaceuticals. Their pre-clinical candidate vaccine uses a unique platform that sets it apart from other efforts to fight the pandemic. We spoke to Tonix CEO Seth Lederman to find out more.
Two teams of scientists in Italy have collaborated on a project that further analyzed the SARS-CoV-2 genome from locally acquired samples. Technology Networks spoke with Professor Stefano Menzo, virologist, and Dr. Valerio Onofri, geneticist, affiliates of the Department of Excellence of Biomedical Science and Public Health, Marche Polytechnic University in Ancona, to learn more about the findings.
Technology Networks recently spoke to David O’Reilly, PhD, Director of Scientific Research at BAT to learn more about the tobacco plant “biomanufacturing factories” that are being used to develop a COVID-19 vaccine. We also discuss the challenges faced when developing a vaccine and the benefits tobacco plants offer compared to conventional vaccine development methods.Read More
Technology Networks recently spoke with Ofer Sharon, CEO of OncoHost, to learn more about ways to overcome patient resistance to immunotherapy and how proteomic profiling in oncology can aid diagnosis, prognosis and treatment of this incredibly complex disease.Read More
Technology Networks spoke to Michael Feldschuh, CEO, Daxor, to learn more about the importance of maintaining optimal blood volume, how the BVA-100 test can help to measure this, and how clinicians can use the information it provides to guide treatment of COVID-19 patients.Read More
Technology Networks recently spoke to Dr Andy Lane, Commercial Director, The Native Antigen Company, to learn how SARS-CoV-2 antigens and antibodies can be used to drive the development of COVID-19 diagnostics.Read More
Here, we outline which vaccine candidates against COVID-19 are currently in human clinical trials.Read More
Whilst scientists work tirelessly to develop an effective COVID-19 vaccine as a long-term preventive strategy, in parallel, researchers are also exploring the therapeutic potential of existing drugs as an efficient immediate approach. We recently had the pleasure of speaking with Alan Fletcher, VP/GM, Life Sciences at PerkinElmer, Inc. to learn about the benefits and challenges of repurposing a drug in this context.Read More
The COVID-19 outbreak has accelerated the digitization of healthcare. “Digital pharmacy” Genius Rx says it will trial same-day couriered delivery of scripts to patients’ doors from this summer. We spoke to Randy about the process of getting medication online and how analytics technology could save patients money.Read More